Technology Transfer for Biopharmaceuticals（生物医药品的技术移转）
CSS
学会概要
Mix-and-match sessions from these additional co-located conferences at no additional cost:
- Process & Product Validation
- Outsourcing Manufacturing of Biopharmaceuticals
- Biopharmaceutical Raw Materials throughout the Product Lifecycle
- Viral Safety for Biologicals
Stay for the week so you can attend on Feb. 29 - March 2 for these conferences:
- Antibody Development & Production
- Recombinant Protein & Complex Biologic Development & Production
- Analytical Technologies for Biotherapeutic Development
- Biobetters & Biosimilars: Technologies & Development Strategies
Get the Most Out of Your Budget with the "All Access Pass" to Attend Sessions from All 9 Conferences
View the Agenda-At-A-Glance for the Entire Week.
此学会将风险控制在最小限度，提高生产率，实现有效率且顺畅的技术移转，同时介绍解决技术移转时各种课题的秘诀。
- 将技术转移给医药品制造受托机关(CMO)，排除委托生产业务时产生的风险要因
- 为实现高柔软性的多品种大规模生产体制之设施设计和技术转移策略
- 生物医药品复合制程技术移转的课题及应检讨的要点
- 为维持有益的合作关系，设计技术移转的基础、管理与实施方法的手法
- 维持合作关系，促进技术移转，保护智能财产的方法
- 原料和供应链的管理，及对技术移转和外包的影响
重点演讲
Biologics Product & Process Lifecycle Management: Genentech / Roche Experience
David Chang, Ph.D.
Senior Director, Global Biologics Manufacturing Science & Technology
Genentech, Inc., a member of the Roche group
Facility Fit Analysis – The First Step in a Long Journey
Greg Liposky, Ph.D.
Vice President & General Manager, Site Operations
MedImmune
特别演讲
Avoiding Pitfalls During Tech Transfer - Mitigate Risks, Drive Efficiencies and Accelerate Timelines
Michael Pohlscheidt, Ph.D., EMBA
Associate Director, MSAT
Genentech
2012年计画值得一看的地方
- 技术移转时的危机管理
- 确保技术移转时设施的柔软性和准备
- 克服技术移转课题的个案研究
- 技术移转时维持良好的合作关系
- 委托外部生产的策略和重要业绩评价指标(KPI)的判断
- 供应链的危机管理
- 对供应商供应的原料之评价和品质控制